Cancer and brain disease constitute significant medical challenges. Diagnosis and therapy necessitates the continuous development of new technologies.
Nowadays, the understanding and treatment of diseases relies heavily on the identification of the underlying molecular and cellular mechanisms. These, however, require novel bio-analytical methods and tools for identifying cellular phenotypes and molecular changes that could be exploited towards the design of effective therapies.